Type: Cluster Project page: Access page Country: Austria Synopsis: The MedTech-Cluster of Business Upper Austria, the Upper Austrian Business Agency is the main interface between industry, science and medicine. In total, the MTC’s network consists of approx. 230 partners, whereby the MedTech-Cluster’s aim is to bring together relevant players from the MedTech-industry in order to...
Type: Cluster Project page: Access page Country: Austria Synopsis: Human.technology Styria is active in two strategic fields of strength – MedTech as well as Pharma & BioTech – with the vision to generate economic and intellectual added value for members, partners, and customers through joint progress. Additionally, it is developing European lighthouse projects like the...
Type: Project page: Access page Country: Austria Synopsis: The activity is non-profit and non-profit-making, aims to promote cooperation between people working together in the field of natural and technical sciences on the one hand and the biology and medicine, on the other hand, are interested. The main objectives of the company are: Promoting and linking...
Type: Cluster Project page: Access page Country: Austria Synopsis: Life Science Austria (LISA) promotes the life science sector in Austria on the international stage and is the first point of call for enquiries relating to it. LISA is committed to the development, growth and prosperity of the Austrian life science industries as a leading component...
Dates: 01/01/2021 31/12/2025 Topic: Tool Procedures Project type: Preclinic Project target: Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSITAETSKLINIKUM WUERZBURG – KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT Keywords: Countries: Germany; UK; Italy; France; Austria; Spain; Belgium; Luxembourg; Switzerland Project page: Access page...
Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Project type: Preclinic Clinic Project target: Digestive disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: HUMANITAS UNIVERSITY Keywords: bowel disease; biomarker; dermatitis; ulcerative colitis; liquid biopsy; OMICs; IMID Countries: Italy; Austria; Germany; UK; Netherlands; Belgium;...
Dates: 01/01/2020 31/12/2023 Topic: Biomarkers identification Project type: Immunotherapy Project target: Autoimmune disease Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: Radboud University Medical Center -ELLINIKO INSTITUTO MELETIS TIS SIPSIS -CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS -UNIVERSITATSKLINIKUM JENA -ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT...
Dates: 01/09/2016 31/08/2023 Topic: Biomarkers identification Project type: Preclinic Project target: Endocrine disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: LUNDS UNIVERSITET -HELSINGIN YLIOPISTO -ACADEMISCH ZIEKENHUIS GRONINGEN -ITA-SUOMEN YLIOPISTO -UNIVERSITY OF DUNDEE -THE UNIVERSITY OF EXETER -Istituto di Ricerche Farmacologiche Mario...
Dates: 01/02/2018 31/07/2023 Topic: Tool AI/Big Data Project type: Preclinic Project target: Neurology Cardiovascular disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5. – Methods and data Participating agents: UNIVERSITEIT MAASTRICHT Keywords: drug repurposing; biomarker; cerebro-cardiovascular; in-silico; clinical trial; efficacy Countries: Denmark; UK; Germany; Netherlands; Austria Project page: Access page
Dates: 01/01/2019 31/05/2023 Topic: Tool AI/Big Data Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5.3. – Using in-silico medicine for improving disease management and prediction Other Participating agents: TECHNIKON FORSCHUNGS- UND PLANUNGSGESELLSCHAFT MBH Keywords: paediatric; oncology; big data; cancer; machine learning; stadistics; tumour; clinical...